Northern Trust’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $5.66M | Buy |
78,598
+22,522
| +40% | +$1.28M | ﹤0.01% | 2392 |
|
|
2025
Q4 | $2.37M | Buy |
56,076
+17,586
| +46% | +$984K | ﹤0.01% | 2897 |
|
|
2025
Q3 | $2.19M | Buy |
38,490
+14,346
| +59% | +$475K | ﹤0.01% | 2991 |
|
|
2025
Q2 | $624K | Sell |
24,144
-70,334
| -74% | -$790K | ﹤0.01% | 3585 |
|
|
2025
Q1 | $964K | Buy |
94,478
+146
| +0.2% | +$1.91K | ﹤0.01% | 3303 |
|
|
2024
Q4 | $1.32M | Buy |
94,332
+855
| +0.9% | +$15.1K | ﹤0.01% | 3254 |
|
|
2024
Q3 | $1.82M | Buy |
93,477
+63,494
| +212% | +$1.21M | ﹤0.01% | 3059 |
|
|
2024
Q2 | $558K | Buy |
29,983
+6,040
| +25% | +$127K | ﹤0.01% | 3468 |
|
|
2024
Q1 | $336K | Sell |
23,943
-4,465
| -16% | -$46.7K | ﹤0.01% | 3706 |
|
|
2023
Q4 | $241K | Buy |
28,408
+4,413
| +18% | +$33.4K | ﹤0.01% | 3830 |
|
|
2023
Q3 | $214K | Sell |
23,995
-395
| -2% | -$3.8K | ﹤0.01% | 3787 |
|
|
2023
Q2 | $210K | Sell |
24,390
-94,575
| -79% | -$1.01M | ﹤0.01% | 3811 |
|
|
2023
Q1 | $1.25M | Sell |
118,965
-5,536
| -4% | -$167K | ﹤0.01% | 3140 |
|
|
2022
Q4 | $4.22M | Buy |
124,501
+25
| +0% | +$1.21K | ﹤0.01% | 2588 |
|
|
2022
Q3 | $5.98M | Buy |
124,476
+64,986
| +109% | +$3.87M | ﹤0.01% | 2355 |
|
|
2022
Q2 | $3.39M | Sell |
59,490
-5,381
| -8% | -$340K | ﹤0.01% | 2757 |
|
|
2022
Q1 | $5.25M | Sell |
64,871
-2,659
| -4% | -$394K | ﹤0.01% | 2561 |
|
|
2021
Q4 | $13.7M | Sell |
67,530
-32,296
| -32% | -$7.01M | ﹤0.01% | 2029 |
|
|
2021
Q3 | $26.9M | Buy |
99,826
+2,203
| +2% | +$530K | ﹤0.01% | 1575 |
|
|
2021
Q2 | $25.1M | Sell |
97,623
-3,440
| -3% | -$952K | ﹤0.01% | 1730 |
|
|
2021
Q1 | $30.3M | Buy |
101,063
+8,638
| +9% | +$2.69M | 0.01% | 1528 |
|
|
2020
Q4 | $23.6M | Sell |
92,425
-2,415
| -3% | -$624K | ﹤0.01% | 1681 |
|
|
2020
Q3 | $23.6M | Sell |
94,840
-3,538
| -4% | -$1.11M | 0.01% | 1498 |
|
|
2020
Q2 | $34.2M | Buy |
98,378
+1,014
| +1% | +$316K | 0.01% | 1190 |
|
|
2020
Q1 | $26.1M | Buy |
97,364
+2,886
| +3% | +$893K | 0.01% | 1211 |
|
|
2019
Q4 | $30.6M | Sell |
94,478
-39,160
| -29% | -$11.4M | 0.01% | 1388 |
|
|
2019
Q3 | $36.5M | Buy |
133,638
+1,906
| +1% | +$699K | 0.01% | 1210 |
|
|
2019
Q2 | $70.3M | Buy |
131,732
+9,235
| +8% | +$4.63M | 0.02% | 754 |
|
|
2019
Q1 | $61.7M | Buy |
122,497
+2,867
| +2% | +$1.7M | 0.02% | 815 |
|
|
2018
Q4 | $59M | Sell |
119,630
-229
| -0.2% | -$138K | 0.02% | 745 |
|
|
2018
Q3 | $110M | Buy |
119,859
+8,288
| +7% | +$7.07M | 0.03% | 521 |
|
|
2018
Q2 | $81.7M | Sell |
111,571
-62,150
| -36% | -$71.7M | 0.02% | 656 |
|
|
2018
Q1 | $277M | Buy |
173,721
+48,264
| +38% | +$62.2M | 0.07% | 271 |
|
|
2017
Q4 | $112M | Sell |
125,457
-2,504
| -2% | -$1.48M | 0.03% | 522 |
|
|
2017
Q3 | $46.1M | Sell |
127,961
-1,196
| -0.9% | -$374K | 0.01% | 1021 |
|
|
2017
Q2 | $37.9M | Buy |
129,157
+8,686
| +7% | +$2.51M | 0.01% | 1154 |
|
|
2017
Q1 | $42.4M | Buy |
120,471
+2,707
| +2% | +$608K | 0.01% | 1047 |
|
|
2016
Q4 | $21.7M | Buy |
117,764
+13,125
| +13% | +$2.67M | 0.01% | 1555 |
|
|
2016
Q3 | $27M | Sell |
104,639
-134
| -0.1% | -$34.5K | 0.01% | 1336 |
|
|
2016
Q2 | $22.4M | Sell |
104,773
-1,084
| -1% | -$242K | 0.01% | 1437 |
|
|
2016
Q1 | $21.8M | Buy |
105,857
+1,727
| +2% | +$332K | 0.01% | 1434 |
|
|
2015
Q4 | $26.3M | Buy |
104,130
+2,458
| +2% | +$505K | 0.01% | 1285 |
|
|
2015
Q3 | $16.7M | Buy |
101,672
+8,103
| +9% | +$1.43M | 0.01% | 1623 |
|
|
2015
Q2 | $17.6M | Sell |
93,569
-1,703
| -2% | -$293K | 0.01% | 1687 |
|
|
2015
Q1 | $15.7M | Buy |
95,272
+1,418
| +2% | +$291K | ﹤0.01% | 1763 |
|
|
2014
Q4 | $21.8M | Sell |
93,854
-2,828
| -3% | -$604K | 0.01% | 1471 |
|
|
2014
Q3 | $17.5M | Sell |
96,682
-4,568
| -5% | -$874K | 0.01% | 1613 |
|
|
2014
Q2 | $19.5M | Sell |
101,250
-9,302
| -8% | -$1.65M | 0.01% | 1535 |
|
|
2014
Q1 | $20.1M | Sell |
110,552
-689
| -0.6% | -$136K | 0.01% | 1566 |
|
|
2013
Q4 | $18.9M | Buy |
111,241
+2,060
| +2% | +$332K | 0.01% | 1571 |
|
|
2013
Q3 | $17.1M | Sell |
109,181
-949
| -0.9% | -$175K | 0.01% | 1585 |
|
|
2013
Q2 | $19.1M | Buy |
+110,130
| New | +$16.9M | 0.01% | 1421 |
|
Other funds holding NKTR
BI
TSC
VCM
PM
AC
Northern Trust's NKTR Position: Q1 2026 in Review
Northern Trust increased its Nektar Therapeutics (NKTR) stake by 40% in Q1 2026, buying an estimated $1.28M and bringing the position to 78,598 shares worth $5.66M. The position accounts for ﹤0.01% of the portfolio, ranked #2392.
Northern Trust first reported a position in NKTR in Q2 2013 and has held it in 52 quarters since. The position peaked at $277M in Q1 2018. 215 funds tracked by Wall St. Rank hold NKTR as of Q1 2026.
- Northern Trust held 78,598 shares of Nektar Therapeutics worth $5.66M as of Q1 2026.
- Northern Trust bought 22,522 Nektar Therapeutics shares in Q1 2026, an estimated $1.28M.
- Nektar Therapeutics made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #2392 holding.
- Northern Trust first reported a position in Nektar Therapeutics in Q2 2013 and has held it in 52 quarters since.
- Northern Trust's Nektar Therapeutics position peaked at $277M in Q1 2018.
- 215 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2026.
Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.